>
网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
P-gp和p53蛋白在大肠癌细胞中的表达及其临床意义
作者:李俐 赵建华 樊克武 
单位:南京市第一医院病理科,
关键词:P-糖蛋白 p53蛋白 大肠癌 预后 多药耐药 
分类号:R735.34, Q754
出版年·卷·期(页码):2001·20·第二期(114-115)
摘要:

目的:探讨大肠癌细胞中P-糖蛋白(P-gp)和p53蛋白的表达情况及其临床意义。方法:采用SP免疫组织化学法对64例大肠癌标本进行检测。结果:64例中有44例大肠癌标本的P-gp和p53蛋白表达一致,二者的表达有相关性;其中19例二者均为阳性表达,25例均为阴性表达,并且P-gp和p53蛋白在(Ⅲ加Ⅳ)组的阳性率显著高于(Ⅰ加Ⅱ)组。结论:大肠癌中P-gp和p53蛋白的表达密切相关,二者共同表达提示患者预后不良。

Objective  To investigate the expression of P  gp and p53 protein in colorectal carcinoma cells and their clinical significance.Methods  64 cases of colorectal carcinoma were examined by S  P immunohistochemical method.Results  The uniformity of P  gp and p53 protein expression was found in 44 patients.Co  expression of P  gp and p53 was more frequently observed in group(Ⅲ+Ⅳ) than in group(Ⅰ+Ⅱ).Conclusion  The expression of p53 protein is offen associated with P  gp expression in colorectal carcinoma,co  expression of P  gp and p53 results in more aggressive phenotype,drug resistance and poor prognosis.

参考文献:

[1] Bradley G, JURANKA PF, LING V. Mechanism of multidrug resistance, 1998
[2] Chin KV, UEDA K, Pastan I. Modulation of activity of the promoter of the human MDR1 gene by Ras and p53. 1992. doi:10.1126/science.1346476
[3] Schneider J, BAK M, EFFERTH TH. P-glyco-protein expression in treated and untreated human breast cancer, 1989
[4] GreenblattMS, BENNETT WP, Hollstein M. Mutations in the p53 tumor suppressor gene:clues to cancer etiology and molecular pathogenesis, 1994
[5] GOLDSMITH M E, GUDAS J M, Schneider E. Wild type p53 stimulates expression from the human multidrug resistance promoter in a p53-negative cell line. 1995. doi:10.1074/jbc.270.4.1894 

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 466080 位访问者


copyright ©《东南大学学报(医学版)》编辑部
联系电话:025-83272481 83272483
电子邮件:
bjb@pub.seu.edu.cn

本系统由北京博渊星辰网络科技有限公司设计开发 技术支持电话:010-63361626

苏ICP备09058364